Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.
about
Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Elacridar, a third-generation ...... in non-small cell lung cancer.
@en
type
label
Elacridar, a third-generation ...... in non-small cell lung cancer.
@en
prefLabel
Elacridar, a third-generation ...... in non-small cell lung cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Elacridar, a third-generation ...... in non-small cell lung cancer
@en
P2093
Haiyang Chen
Hidejiro Torigoe
Hiroaki Asano
Hiroki Sato
Hiromasa Yamamoto
Ken Suzawa
Mototsugu Watanabe
Shinichi Toyooka
Shinichiro Miyoshi
P2860
P304
P356
10.3892/OL.2017.6678
P577
2017-07-26T00:00:00Z